Related Experiment Videos

Decreased intestinal absorption of methotrexate in the rat following repeated oral dosing

Research Communications in Chemical Pathology and Pharmacology
|April 1, 1985
PubMed

Insights

Oral methotrexate (MTX) absorption in rats is poor and worsens with repeated dosing. Even with impaired clearance, repeated oral MTX did not increase plasma levels, indicating reduced intestinal absorption over time.

Area of Science:

  • Pharmacokinetics
  • Drug Absorption
  • Toxicology

Background:

  • Methotrexate (MTX) is a crucial chemotherapy agent.
  • Understanding MTX oral bioavailability is vital for effective treatment regimens.
  • Previous studies suggest variable oral absorption of MTX.

Purpose of the Study:

  • To investigate the oral absorption of methotrexate in rats after single and repeated administrations.
  • To compare oral MTX absorption with intravenous administration.
  • To evaluate the impact of repeated dosing intervals on MTX absorption and plasma concentrations.

Main Methods:

  • Oral and intravenous administration of MTX in rats.
  • Dosing regimens included single and repeated doses (72-hour intervals).
  • Plasma MTX concentrations and renal clearance were monitored.

Main Results:

  • Poor oral absorption of MTX (14.7%) was observed after single and repeated doses.
  • Repeated oral administration did not enhance plasma MTX concentrations.
  • Impaired renal clearance did not lead to higher plasma MTX levels with repeated oral dosing.

Conclusions:

  • Oral administration of MTX in rats results in incomplete intestinal absorption.
  • Repeated oral MTX dosing at 72-hour intervals exacerbates the initial poor absorption.
  • The study highlights the limitations of oral MTX delivery in rats, even with compromised renal function.

Related Concept Videos